You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 7,994,223


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,994,223
Title:Amide derivatives as positive allosteric modulators and methods of use thereof
Abstract: The invention relates to novel amide derivatives that are positive allosteric modulators of neuronal nicotinic receptors, compositions comprising the same, processes for preparing such compounds, and methods for using such compounds and compositions.
Inventor(s): Schrimpf; Michael R. (Grayslake, IL), Mortell; Kathleen H. (Chicago, IL), Nersesian; Diana L. (Gurnee, IL), Lee; Chih-Hung (Vernon Hills, IL), Clapham; Bruce (Lindenhurst, IL)
Assignee: Abbott Laboratories (Abbott Park, IL)
Application Number:12/841,547
Patent Claims:1. A method of treating a disorder or condition selected from the group consisting of acute pain, post-surgical pain, inflammatory pain, and neuropathic pain, comprising administering a therapeutically effective amount of a compound of formula (I): ##STR00009## wherein, A is --C(O)NH--; R.sup.a, R.sup.b, and are independently hydrogen, alkenyl, alkoxy, alkoxycarbonyl, alkyl, alkylcarbonyl, alkylsulfonyl, alkylthio, cyano, haloalkoxy, haloalkyl, or halogen; R.sup.x at each occurrence is independently acyloxy, alkoxy, alkyl, haloalkyl, halogen, or hydroxy; n is 0, 1, 2, 3, or 4; R.sup.1 is hydrogen or halogen; R.sup.2 and R.sup.3 are independently hydrogen, alkenyl, alkoxy, alkoxycarbonyl, alkyl, alkylcarbonyl, alkylsulfonyl, alkylthio, cyano, haloalkoxy, haloalkyl, halogen or NR.sup.5R.sup.6, provided that at least one of R.sup.2 or R.sup.3 is NR.sup.5R.sup.6; R.sup.5 and R.sup.6 are independently hydrogen, alkenyl, alkoxyalkyl, alkoxycarbonyl, alkyl, alkylcarbonyl, alkylsulfonyl, arylalkyl, cycloalkyl, cycloalkylalkyl, haloalkyl, heteroarylalkyl, heterocycle, or heterocyclealkyl; or a pharmaceutically acceptable salt, ester, or amide thereof.

2. The method of claim 1, further comprising administering in combination with atypical antipsychotics, cholinesterase inhibitors, histamine M3 antagonists, 5HT2.sub.c antagonists, 5HT-6 antagonists, dopamine D1 agonists, muscarinic receptor antagonists, potassium channel blockers, .alpha.7 NNR ligands, or .alpha.4.beta.2 NNR ligands.

3. The method of claim 1, wherein R.sup.1 is hydrogen or fluorine.

4. The method of claim 1, wherein R.sup.5 and R.sup.6 are independently selected from hydrogen, alkyl, alkoxycarbonyl, alkylcarbonyl, alkylsulfonyl, arylalkyl, cycloalkyl, cycloalkylalkyl, haloalkyl, and heteroarylalkyl.

5. The method of claim 1, wherein the compound is selected from the group consisting of: N-[4-(acetylamino)benzyl]-4-[(trifluoromethyl)thio]benzamide; N-[4-(diethylamino)benzyl]-4-[(trifluoromethyl)thio]benzamide; N-{3-[(methylsulfonyl)amino]benzyl}-4-[(trifluoromethyl)thio]benzamide; N-[3-(methylamino)benzyl]-4-[(trifluoromethyl)thio]benzamide; N-{4-[(methylsulfonyl)amino]benzyl}-4-[(trifluoromethyl)thio]benzamide; N-[3-(dimethylamino)benzyl]-4-[(trifluoromethyl)thio]benzamide; N-{3-[acetyl(methyl)amino]benzyl}-4-[(trifluoromethyl)thio]benzamide; N-[4-(dimethylamino)benzyl]-4-[(trifluoromethyl)thio]benzamide; N-(4-aminobenzyl)-4-[(trifluoromethyl)thio]benzamide; N-[4-(methylamino)benzyl]-4-[(trifluoromethyl)thio]benzamide; 4-[(difluoromethyhthio]-N-[4-(dimethylamino)benzyl]benzamide; and 4-[(difluoromethyhthio]-N-[4-(methylamino)benzyl]benzamide; or a pharmaceutically acceptable salt thereof.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.